glp-1 deaths Glucagon-like peptide-1 receptor agonists and risk of suicidality among patients with type 2 diabetes: active comparator, new user cohort study Most Patients Discontinue GLP-1 Drugs

This is a type of anemia that is often distinguished by the lack of an intrinsic factor

And they certainly do not all require the same response

Ophthalmic Complications Associated With the Antidiabetic Drugs Semaglutide and Tirzepatide Katz BJ et al

Brand-name medications such as Wegovy and Zepbound cost significantly more, and availability depends on clinical eligibility

GLP-1 RAs showed trends toward improvements in endocrine and metabolic, cardiovascular, renal, and respiratory outcomes, cognitive function, with a potential reduction in fracture risk and all-cause mortality in certain populations

Whats different about these peptides